NASDAQ:TLRY (Tilray)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Tilray (NASDAQ: TLRY) Latest News

Investing
Aurora Cannabis Inc (TSX:ACB) vs Tilray Inc (NASDAQ:TLRY): Which Is the Better Buy?

Investing
Why You Should Buy Tilray (NASDAQ:TLRY) Stock and Forget About It

Investing
Is Canopy Growth Corp (TSX:WEED) About to Be Dethroned?

Investing
Should You Buy Tilray Inc. (TSX:TLRY) or Canopy Growth Corp (TSX:WEED) Stock?

Investing
3 Marijuana Stocks to Watch in 2019

Investing
Are Marijuana Stocks Worth Betting On in 2019?

Dividend Stocks
The 5 Biggest Stock Market Winners of 2018
Investing
3 Marijuana Stocks That Could Surprise Everyone in 2019

Investing
2 Popular Marijuana Stocks I’d Avoid in Early 2019
Investing
2 Top Marijuana Stocks to Watch in 2019

Investing
3 Reasons to Avoid Marijuana Stocks in 2019
